Chroman derivatives

US5112839A · kind A · utility

Assignee

• Merck Patent GmbH · DE

Inventors

• Rolf Gericke · Seeheim-Jugenheim, DE
• Manfred Baumgarth
• Ingeborg Lues · Darmstadt, DE
• Rolf Bergmann
• Jacques De Peyer · Darmstadt, DE

Key dates

• Filing date: Jul 6, 1990
• Grant date: May 12, 1992
• Expiry date: Jul 6, 2010

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61P25/02
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Novel chroman derivatives of the formula I ##STR1## in which R.sup.1 to R.sup.10 have the meanings given in patent claim 1, and their salts show effects on the cardiovascular system and can be used for the treatment or prophylaxis of cardiac insufficiency, angina pectoris, high blood pressure, incontinence and alopecia.